Matsushita, M.* ; Awazawa, M.* ; Kobayashi, N.* ; Ikushima, Y.M.* ; Soeda, K.* ; Tamura-Nakano, M.* ; Muratani, M.* ; Kobayashi, K.* ; Blüher, M. ; Brüning, J.C.* ; Ueki, K.*
An antisense transcript transcribed from Irs2 locus contributes to the pathogenesis of hepatic steatosis in insulin resistance.
Cell Chem. Bio. 29, 680-689.e6 (2022)
During insulin resistance, lipid uptake by the liver is promoted by peroxisome proliferator-activated protein (PPAR) γ upregulation, leading to hepatic steatosis. Insulin, however, does not directly regulate adipogenic gene expression in liver, and the mechanisms for its upregulation in obesity remain unclear. Here, we show that the Irs2 locus, a critical regulator of insulin actions, encodes an antisense transcript, ASIrs2, whose expression increases in obesity or after refeeding in liver, reciprocal to that of Irs2. ASIrs2 regulates hepatic Pparg expression, and its suppression ameliorates steatosis in obese mice. The human ortholog AL162497.1, whose expression is correlated with that of hepatic PPARG and the severity of non-alcoholic steatohepatitis (NASH), shows genomic organization similar to that of ASIrs2. We also identified HARS2 as a potential binding protein for ASIrs2, functioning as a regulator of Pparg. Collectively, our data reveal a functional duality of the Irs2 gene locus, where reciprocal changes of Irs2 and ASIrs2 in obesity cause insulin resistance and steatosis.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Pparg ; Fatty Liver ; Insulin Resistance ; Natural Antisense Transcript ; Non-coding Rna
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2022
Prepublished im Jahr
0
HGF-Berichtsjahr
2022
ISSN (print) / ISBN
2451-9448
e-ISSN
2451-9456
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 29,
Heft: 4,
Seiten: 680-689.e6
Artikelnummer: ,
Supplement: ,
Reihe
Verlag
Cell Press
Verlagsort
Cambridge, Massachusetts
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
Institut(e)
Helmholtz Institute for Metabolism, Obesity and Vascular Research (HI-MAG)
POF Topic(s)
30201 - Metabolic Health
Forschungsfeld(er)
Helmholtz Diabetes Center
PSP-Element(e)
G-506501-001
G-506500-001
Förderungen
Copyright
Erfassungsdatum
2022-05-31